The aim was to explore the prevalence of visitors to CAM practitioners in a total population with reference to sex, self-rated health status and socio-demographic characteristics. Methods:
The paper reports findings from the Nord-Trøndelag Health Study (HUNT 2), a total population-based health survey of 42,277 respondents conducted in central Norway who answered questions on visits to a CAM practitioner. Variables included were age, marital status, education, receiving social welfare benefits, lifestyle (daily smoker), Hospital Anxiety and Depression Scale (HADS-T), self-rated health status, and having a limiting chronic complaint. Results:
Some 12.8% (95% CI 12.5–13.1) of the population had visited a CAM practitioner in the last 12 months, with females visiting almost twice as often as males. Multivariate analysis showed that consulting a CAM practitioner was significantly associated in both sexes with being middle-aged (male age 40–49 OR 1.6 (1.2–2.0), female age 30–39 OR 1.4 (1.1–1.6)); poor self-rated health status (male OR 5.1 (3.1–8.5), female 3.9 (2.2–6.8 )); and reporting a chronic complaint (male OR 1.5 (1.3–1.8), female OR 1.4 (1.2–1.6)). Daily smoking of cigarettes was associated with a decreased likelihood for visiting a CAM practitioner (male OR 0.7 (0.6–0.9), female OR 0.8 (0.7–0.9)). In females, both a higher total HADS-T score (score >20 OR 1.5 (1.2–2.0)) and middle-level education (OR 1.2 (1.1–1.4)) were associated with visiting a CAM practitioner. Conclusions:
Visitors to CAM practitioners had lower self-reported health than non-users, but socio-demographic variables did not discriminate between users and non-users.
Dr. Aslak Steinsbekk Department of Public Health and General Practice Norwegian University of Science and Technology (NTNU) 7489 Trondheim, Norway Tel. +47 73 597574, Fax 597577 E-mail email@example.com
Published online: June 9, 2008
Number of Print Pages : 6
Number of Figures : 0, Number of Tables : 4, Number of References : 18
Forschende Komplementärmedizin / Research in Complementary Medicine (Research Practice Perspectives - Wissenschaft Praxis Perspektiven)
Vol. 15, No. 3, Year 2008 (Cover Date: July 2008)
Journal Editor: Walach H. (Northampton)
ISSN: 1661–4119 (Print), eISSN: 1661–4127 (Online)
For additional information: http://www.karger.com/FOK
Copyright / Drug Dosage
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.